TECH Share Price

Open 117.78 Change Price %
High 118.40 1 Day -0.29 -0.25
Low 116.78 1 Week 1.29 1.12
Close 116.95 1 Month 4.06 3.60
Volume 144739 1 Year 5.47 4.91
52 Week High 119.98
52 Week Low 95.68
TECH Important Levels
Resistance 2 118.45
Resistance 1 117.83
Pivot 117.38
Support 1 116.07
Support 2 115.45
NASDAQ USA Most Active Stocks
YHOO 52.58 0.00%
YHOO 52.58 0.00%
YHOO 52.58 0.00%
FNFG 10.18 -0.20%
DCTH 0.16 0.00%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
AEZS 2.34 129.41%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
More..
NASDAQ USA Top Gainers Stocks
AEZS 2.34 129.41%
SCHS 0.05 66.67%
LOCM 0.09 50.00%
MYRX 0.08 33.33%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
CPSL 0.11 22.22%
VRTX 159.69 20.83%
ENG 1.40 19.66%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
ZOOM 0.02 -80.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
CPWR 3.00 -52.00%
AMCF 0.01 -50.00%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
QKLS 0.11 -47.62%
More..

Techne Corporation (NASDAQ: TECH)

TECH Technical Analysis 5
As on 19th Jul 2017 TECH Share Price closed @ 116.95 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 106.70 & Strong Buy for SHORT-TERM with Stoploss of 113.45 we also expect STOCK to react on Following IMPORTANT LEVELS.
TECH Target for July
1st Target up-side 123.42
2nd Target up-side 127.57
3rd Target up-side 131.72
1st Target down-side 111.58
2nd Target down-side 107.43
3rd Target down-side 103.28
TECH Other Details
Segment EQ
Market Capital 2603798528.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.techne-corp.com
TECH Address
TECH
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States
Phone: 612-379-8854
Fax: 612-379-6580
TECH Latest News
Interactive Technical Analysis Chart Techne Corporation ( TECH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Techne Corporation
TECH Business Profile
TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide. In July 2013, the Company announced that it has completed the acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).